ACTION_TD1002 AFM4NanoMed

1
ACTION_TD1002 AFM4NanoMedBio 13/12/2010
12/12/2014
European network on applications of Atomic Force
Microscopy to NanoMedicine and Life Sciences
Participating countries (24) AT BE HR DK FI FR
DE GR HU IE IL IT LT LU NL NO PL PT RO RS ES CH
TR UK Action Chair Pierre Parot (FR),
parot_at_cea.fr Rapporteurs Pavle Andjus (RS),
pandjus_at_bio.bg.ac.rs Spiros H. Anastasiadis (EL)
spiros_at_iesl.forth.gr Science Officer Giuseppe
Lugano, giuseppe.lugano_at_cost.eu Action website
www.afm4nanomedbio.eu Kickoff Meeting took place
on December 13th 2010 Next MC Meeting
Sêptember 2013, Dubrovnik
TDP
The main objective of the Action is to further
develop and transfer the biophysical
achievements of Atomic Force Microscopy to
NanoMedicine and clinical research.
Management Committee (MC) Chair Pierre Parot
Vice-Chair Hans Oberleithner Task Group
Coordinator Jean-Luc Pellequer
Working Group Coordinators
WG 1 Simon Scheuring
Imaging from molecules to cells Fundamental WG
that uses the basic strength of AFM High
Resolution Imaging
WG 2 Salvatore Cannistraro
Dynamic Force spectroscopy on Molecules and Cells
WG promoting fundamental research based on the
piconewton force sensitivity of AFM.
WG 3 Peter Schöen
NanoMedicine Nanodiagnosis Nanosensing Applied
WG that uses AFM with additional techniques
fluorescence, Raman, ion measurements
WG 4 Vesna Svetlicic 
Environmental Nanotoxicology and Nanoparticles
Applied WG that evaluates the use of AFM as a
tool in nanoecology and nanotoxicology and
 health risk assessment
WG 5 Ricardo Garcia
New Instrumentation and Techniques Special WG
in relation with manufacturers concerning the
specifications of standardized AFM Machines
for clinical applications.
ESF provides the COST Office through a European
Commission contract
The Council of the European Union provides the
COST Secretariat
COST is supported by the EU RTD Framework
Programme
http//www.cost.esf.org/